While there was a trend toward increased TAGLN2 mRNA expression in gliomas that are IDH1/2 WT, 1p/19q non-codeleted and astrocytomas in our institutional cohort (Table 1), an inadequate sample number could again explain why the association did not reach statistical significance. This evidence concerns the gene TAGLN2 and glioma.